Naboctate
Naboctate (SP-325) is a synthetic cannabinoid receptor agonist, which has antiemetic, sedative, anxiolytic and anti-glaucoma properties.[1]
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C33H53NO3 |
Molar mass | 511.777 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
References
- Concise dictionary of pharmacological agents: properties and synonyms. p188. ISBN 0-7514-0499-3
Phytocannabinoids |
|
---|---|
Endocannabinoids |
|
Synthetic cannabinoids | |
Allosteric CBR ligands |
|
Endocannabinoid enhancers (inactivation inhibitors) |
|
Anticannabinoids (antagonists/inverse agonists/antibodies) |
|
|
Receptor (ligands) |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (modulators) |
| ||||||||||||
Enzyme (modulators) |
| ||||||||||||
Others |
| ||||||||||||
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.